Project: A NOVEL HYALURONIC ACID-BASED GEL TO CONTROL BLEEDING DURING HIGH RISK SURGERY
| Acronym | HEMOSPHERE (Reference Number: 10921) |
| Duration | 01/04/2017 |
| Project Topic | HEMOSPERE will develop a novel medical device, consisting of a haemostatic gel and dedicated applicator, to treat bleedings during high risk surgery like neurosurgery. With proprietary flow chemistry technology, a unique non-swelling hyaluronic acid-based gel is obtained that is safe for use in space-restricted sites like near critical tissues. This project delivers an optimized gel manufacturing process, a dedicated applicator and the preclinical efficacy and safety data package. |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 6 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | BioMed Elements B.V. | Coordinator | Netherlands |
| 2 | Creamedix GmbH | Partner | Germany |
| 3 | Medmix Systems AG | Partner | Switzerland |
| 4 | Eberhard Karls Universitaet Tuebingen | Partner | Germany |